SAFE
Curcumin C3 complex
Standardised curcuminoid complex (curcumin I, II, III)
Possibly Safe
V2 Verified
Specialty Bioactives
PubMed Studies
4
About
Patented curcuminoid complex (Sabinsa) with standardised ratio of curcumin (77%), demethoxycurcumin (17%), and bisdemethoxycurcumin (6%). Same safety profile as curcumin with improved stability.
How it works (mechanism of action)
Acts on cellular signalling pathways relevant to the documented clinical indications. Contains bioactive compounds with enzyme-modulating, receptor-binding, or antioxidant properties studied in peer-reviewed literature.
👥 Safety by Population
🚫 Contraindications & Warnings
Same as curcumin entry. Anticoagulant interaction. CYP/P-gp inhibition. Iron chelation.
🇪🇺 EU Health Claims Status
Art.13(1)
✓ AuthorisedNon-compliance with the Regulation because on the basis of the scientific evidence assessed, this claimed effect for this food has not been substantiated.
Regulation EU 1924/2006 · ART13 1
Art.13(1)
✓ AuthorisedNon-compliance with the Regulation because on the basis of the scientific evidence assessed, this claimed effect for this food has not been substantiated.
Regulation EU 1924/2006 · ART13 1
Art.13(5)
✓ AuthorisedNon-compliance with the Regulation because on the basis of the scientific evidence assessed, the evidence provided is insufficient to substantiate this claimed effect for this food.
Regulation EU 1924/2006 · ART13 5
🏷️ Other Names
Standardised curcuminoid complex (curcumin I, II, III)